Company · CIK 1817241
Artiva Biotherapeutics, Inc.
| CIK | 1817241 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | CA |
| Listed | ARTV (Nasdaq) |
| First annual or quarterly report | 2024-08-29 |
Offerings
4 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-298088 | 2026-08-06 | 2026-08-14 | 2 | |
| 333-289325 | 2025-08-06 | 2026-05-08 | 3 | |
| 333-280568 | 2024-06-28 | 2024-07-22 | 4 | |
| 333-255135 | 2021-04-08 | 2022-11-01 | 6 |
Filings
17| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-08-14 | EFFECTDeclared effective | 333-298088 | 9999999995-26-002667 |
| 2026-08-06 | S-3Shelf registered | 333-298088 | 0001193125-26-338453 |
| 2026-05-08 | 424B5Shelf takedown | 333-289325 | 0001193125-26-214706 |
| 2025-08-15 | EFFECTDeclared effective | 333-289325 | 9999999995-25-002641 |
| 2025-08-06 | S-3Shelf registered | 333-289325 | 0001193125-25-174570 |
| 2024-07-22 | 424B4Final prospectus | 333-280568 | 0001193125-24-181773 |
| 2024-07-18 | EFFECTDeclared effective | 333-280568 | 9999999995-24-002197 |
| 2024-07-15 | S-1/AAmendment | 333-280568 | 0001193125-24-178806 |
| 2024-06-28 | S-1Registration filed | 333-280568 | 0001193125-24-172230 |
| 2024-05-03 | DRSDraft made public | 377-07214 | 0000950123-24-003803 |
| 2022-11-01 | RWWithdrawn | 333-255135 | 0001193125-22-275086 |
| 2022-06-06 | S-1/AAmendment | 333-255135 | 0001193125-22-168492 |
| 2022-03-07 | S-1/AAmendment | 333-255135 | 0001193125-22-068001 |
| 2022-01-21 | S-1/AAmendment | 333-255135 | 0001193125-22-014926 |
| 2021-12-16 | S-1/AAmendment | 333-255135 | 0001193125-21-358277 |
| 2021-04-08 | S-1Registration filed | 333-255135 | 0001193125-21-110347 |
| 2021-03-02 | DRSDraft made public | 377-04338 | 0000950123-21-003225 |